Use of Insulin-Sensitizing Agents in Patients With Polycystic Ovary Syndrome

    July 2001 in “ Endocrine Practice
    Zachary T. Bloomgarden, Walter Futterweit, Leonid Poretsky
    New to Metformin? There is a guide in the encyclopedia. Read the guide →
    Image
    Studysummary This review discusses the therapeutic use of insulin-sensitizing agents in polycystic ovary syndrome, reporting improved ovulation, insulin sensitivity, and reduction of hyperandrogenism, but calls for larger studies to confirm these effects.
    Automatically generated from the study's abstract, not written by a person, and not a review of the full paper. Not medical advice or a treatment recommendation. Read the original study, and consult a qualified healthcare professional before changing treatment. Full disclaimer
    Discuss this study in the Community →